寡转移性肾上腺皮质癌:影像引导热消融的作用
回顾性纳入16例寡转移性肾上腺皮质癌患者共32个肝肺转移灶,行射频或微波消融,首次增强CT完全消融率97%(29/30),局部肿瘤进展7/29(24.1%),中位局部无进展生存21个月,中位总生存48.6个月;消融提供安全有效的局部控制选择。
要点
- 消融后首次增强CT完全消融率达97%(29/30),局部肿瘤进展率24.1%(7/29)。
- 转移灶大小是局部肿瘤控制的独立预测因子,AUC 0.934。
- 原发灶切除后无进展生存和激素分泌是总生存的独立预测因子。
核心结论
- 影像引导消融对寡转移性肾上腺皮质癌的肝肺转移灶可实现充分的局部肿瘤控制,是多学科管理中安全有效的治疗选择。
研究设计与样本
- 回顾性纳入16例(10例女性,平均年龄41岁)寡转移性肾上腺皮质癌(肝和肺转移)患者,共32个转移灶(4个肺、28个肝),接受射频消融或微波消融。
- 评估首次增强CT完全消融、局部肿瘤进展、局部肿瘤进展无生存、肝脏无病生存和总生存,并分析Ki67、激素分泌、原发肿瘤切除后无进展生存等预后因素的相关性,采用Kaplan-Meier法、log-rank检验和Spearman相关模型。
诊断标准与关键数值
- 完全消融定义为首次增强CT控制时确认,本组为97%(29/30)。
- 局部肿瘤进展组转移灶大小显著大于无进展组(20 mm vs 34.5 mm,p=0.009),转移灶大小是局部肿瘤控制的独立预测因子,AUC 0.934(p=0.0009)。
- 随访中局部肿瘤进展为7/29例(24.1%),中位局部肿瘤进展无生存21个月(±12.6)。
- 肝脏进展见于66%的病例,中位肝脏无病生存25个月;中位总生存48.6个月。
- 原发肿瘤切除后无进展生存和激素分泌是总生存的独立预测因子(p<0.001和p=0.045)。
临床应用与阅片要点
- 消融后首次增强CT可用于确认完全消融,本组完全消融率为97%(29/30)。
- 转移灶大小与局部肿瘤进展相关(进展组34.5 mm vs 无进展组20 mm,p=0.009),阅片报告可关注病灶大小。
- 原发肿瘤切除后无进展生存和激素分泌与总生存相关(p<0.001和p=0.045),可结合这些临床因素解读预后。
局限性
- 本研究为回顾性研究。
- 1例患者(2个病灶)失访。
- 观察到1例主要不良事件(肝内血肿继发右侧血胸)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the impact of image-guided ablation of liver and lung metastases from adrenocortical carcinoma (ACC).
METHODS: Patients with oligometastatic ACC (liver and lung metastases) who underwent image-guided ablation were retrospectively included in the study. Complete ablation (CA) at the first contrast-enhanced CT control, local tumor progression (LTP), local tumor progression-free survival (LTPFS), liver disease-free survival (LDFS), and overall survival (OS) were evaluated. Correlation between outcomes and other prognostic factors (including Ki67, hormonal secretion, and progression-free survival after primary tumor resection (PR-PFS)) was also analyzed. Kaplan-Meier methods, log-rank tests, and Spearman correlation models were applied.
RESULTS: Thirty-two ACC metastases (4 lung and 28 liver) from 16 patients (10 females; mean age 41 years) were treated with RFA or MWA. A single major adverse event was observed (intrahepatic hematoma with subsequent right hemothorax). One patient (2 lesions) was lost to follow-up. CA was obtained in 97% (29/30). During follow-up, LTP was registered in 7/29 cases (24.1%), with a median LTPFS of 21 months (± 12.6). Metastasis size was significantly higher in case of LTP (20 mm vs. 34.5 mm; p = 0.009) and was an independent predictive factor of local tumor control with an AUC of 0.934 (p = 0.0009). Hepatic progression was observed in 66% of the cases, with a median LDFS of 25 months. Median OS was 48.6 months. PR-PFS and hormonal secretion were independent predictors of OS (p < 0.001 and p = 0.045, respectively).
CONCLUSIONS: Image-guided ablation achieves adequate local tumor control of ACC liver and lung metastases, providing a safe and effective treatment option in the multidisciplinary management of the oligometastatic ACC.
KEY POINTS: • Image-guided ablation allows adequate local tumor control in the oligometastatic adrenocortical carcinoma setting. • After percutaneous thermal ablation, complete ablation was achieved in 29 out of 30 lesions (97%). • Lesion size together with primary resection disease-free survival and hormonal secretion play a significant role in determining outcomes.
引用
- Veltri A, Basile D, Calandri M, et al. Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation. Eur Radiol. 2020. PMID: 32621242. doi:10.1007/s00330-020-07019-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。